3 Undervalued Mid-Caps with Big Upside | Business and Finance News

Three mid-cap stocks flying under the radar but brimming with long-term potential: Archer Aviation is building electric air taxis to revolutionize urban mobility, despite certification hurdles and stock dilution risks; CRISPR Therapeutics is pioneering life-changing gene therapies like Casgevy, even as it burns cash and faces steep pricing challenges; and e.l.f. Beauty is dominating the cosmetics market with affordable, high-growth products, despite tariff headwinds. All three have seen recent dips, but their modest market caps and explosive growth trajectories make them compelling bets for patient, high-risk investors. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/9ede073c7860d0cd